1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 12 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaMartin, A.; Gibbs, E.; Sjoquist, K.; Pavlakis, N.; Simes, J.; Price, T.; Shannon, J.; Gill, S.; Jain, V.; Liu, G.; Kannourakis, G.; Kim, Y.; Kim, J.; Goldstein, D.
2015Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literatureChan, D.; Pavlakis, N.; Shapiro, J.; Price, T.; Karapetis, C.; Tebbutt, N.; Segelov, E.; Rosell, R.
2013Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factorsClarke, S.; Karapetis, C.; Gibbs, P.; Pavlakis, N.; Desai, J.; Michael, M.; Tebbutt, N.; Price, T.; Tabernero, J.
2013Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17Vickers, M.; Karapetis, C.; Tu, D.; O'Callaghan, C.; Price, T.; Tebbutt, N.; van Hazel, G.; Shapiro, J.; Pavlakis, N.; Gibbs, P.; Blondal, J.; Lee, U.; Meharchand, J.; Burkes, R.; Rubin, S.; Simes, J.; Zalcberg, J.; Moore, M.; Zhu, L.; Jonker, D.
2010Objective radiological disease control with Sandostatin monotherapy in metastatic neuroendocrine tumoursKhasraw, M.; Townsend, A.; Price, T.; Hart, J.; Bell, D.; Pavlakis, N.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.
2012Management of advanced gastric cancerPrice, T.; Shapiro, J.; Segelov, E.; Karapetis, C.; Pavlakis, N.; Van Custem, E.; Shah, M.; Kang, Y.; Tebbutt, N.
2013Current opinion on optimal treatment for colorectal cancerPrice, T.; Segelov, E.; Burge, M.; Haller, D.; Ackland, S.; Tebbutt, N.; Karapetis, C.; Pavlakis, N.; Sobrero, A.; Cunningham, D.; Shapiro, J.
2016Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancerSchofield, P.; Stockler, M.; Zannino, D.; Tebbutt, N.; Price, T.; Simes, R.; Wong, N.; Pavlakis, N.; Ransom, D.; Moylan, E.; Underhill, C.; Wyld, D.; Burns, I.; Ward, R.; Wilcken, N.; Jefford, M.
2014The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trialsSegelov, E.; Chan, D.; Shapiro, J.; Price, T.; Karapetis, C.; Tebbutt, N.; Pavlakis, N.

Discover